IL92103A0 - 3beta,17beta-hydroxy-substituted steroids,related steroidal compounds and pharmaceutical compositions containing them - Google Patents

3beta,17beta-hydroxy-substituted steroids,related steroidal compounds and pharmaceutical compositions containing them

Info

Publication number
IL92103A0
IL92103A0 IL92103A IL9210389A IL92103A0 IL 92103 A0 IL92103 A0 IL 92103A0 IL 92103 A IL92103 A IL 92103A IL 9210389 A IL9210389 A IL 9210389A IL 92103 A0 IL92103 A0 IL 92103A0
Authority
IL
Israel
Prior art keywords
compounds
hydroxy
17beta
3beta
pharmaceutical compositions
Prior art date
Application number
IL92103A
Other languages
English (en)
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL92103A0 publication Critical patent/IL92103A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0025—Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Silicon Polymers (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL92103A 1988-10-27 1989-10-24 3beta,17beta-hydroxy-substituted steroids,related steroidal compounds and pharmaceutical compositions containing them IL92103A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/263,091 US4882322A (en) 1988-10-27 1988-10-27 3β,17β-hydroxy-substituted steroids and related steroidal compounds

Publications (1)

Publication Number Publication Date
IL92103A0 true IL92103A0 (en) 1990-07-12

Family

ID=23000340

Family Applications (1)

Application Number Title Priority Date Filing Date
IL92103A IL92103A0 (en) 1988-10-27 1989-10-24 3beta,17beta-hydroxy-substituted steroids,related steroidal compounds and pharmaceutical compositions containing them

Country Status (18)

Country Link
US (1) US4882322A (fr)
EP (1) EP0366144B1 (fr)
JP (1) JP2750621B2 (fr)
KR (1) KR900006360A (fr)
CN (1) CN1042363A (fr)
AT (1) ATE111478T1 (fr)
AU (1) AU619608B2 (fr)
CA (1) CA2001264C (fr)
DE (1) DE68918219T2 (fr)
DK (1) DK533189A (fr)
ES (1) ES2063801T3 (fr)
FI (1) FI895084A7 (fr)
HU (1) HU204065B (fr)
IL (1) IL92103A0 (fr)
NO (1) NO173097C (fr)
NZ (1) NZ231107A (fr)
PT (1) PT92113B (fr)
ZA (1) ZA898025B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166201A (en) * 1990-11-30 1992-11-24 Merrell Dow Pharmaceuticals Inc. 2β,19-ethylene bridged steroids as aromatase inhibitors
WO1999061055A1 (fr) 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Molecules bifonctionnelles et therapies basees sur celles-ci
AU2004292555A1 (en) * 2003-11-24 2005-06-09 Merck & Co., Inc. Estrogen receptor modulators
CN1886418A (zh) * 2003-11-24 2006-12-27 默克公司 雌激素受体调节剂
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
JP2009508494A (ja) 2005-09-16 2009-03-05 ラプトール ファーマシューティカル インコーポレイテッド Ｃｒを含むタンパク質に対して特異的な受容体−結合タンパク質（ｒａｐ）変異体を含む組成物およびその使用
WO2010095940A2 (fr) 2009-02-20 2010-08-26 To-Bbb Holding B.V. Sustème d'administration de médicament à base de glutathionne
TWI556839B (zh) 2009-05-06 2016-11-11 研究室護膚股份有限公司 包含活性劑－磷酸鈣粒子複合物之皮膚遞送組成物及其使用方法
CN103555806B (zh) * 2013-11-16 2015-05-13 江南大学 一种高效利用亚麻刺盘孢霉合成7α-羟基-雄甾烯酮的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322416A (en) * 1980-06-27 1982-03-30 Merrell Dow Pharmaceuticals Inc. 10-Alkynyl steroids
GB8531747D0 (en) * 1985-12-24 1986-02-05 Erba Farmitalia 10beta-alkynylestrene derivatives

Also Published As

Publication number Publication date
US4882322A (en) 1989-11-21
NO894276D0 (no) 1989-10-26
ZA898025B (en) 1990-07-25
DE68918219D1 (de) 1994-10-20
JPH02174793A (ja) 1990-07-06
HU895457D0 (en) 1990-01-28
PT92113A (pt) 1990-04-30
JP2750621B2 (ja) 1998-05-13
PT92113B (pt) 1995-06-30
CA2001264C (fr) 2001-05-01
NZ231107A (en) 1992-03-26
AU619608B2 (en) 1992-01-30
DE68918219T2 (de) 1995-02-02
FI895084A0 (fi) 1989-10-26
HU204065B (en) 1991-11-28
DK533189A (da) 1990-04-28
EP0366144A1 (fr) 1990-05-02
CN1042363A (zh) 1990-05-23
EP0366144B1 (fr) 1994-09-14
ATE111478T1 (de) 1994-09-15
ES2063801T3 (es) 1995-01-16
HUT52113A (en) 1990-06-28
AU4367989A (en) 1990-05-31
KR900006360A (ko) 1990-05-08
NO894276L (no) 1990-04-30
NO173097C (no) 1993-10-27
FI895084A7 (fi) 1990-04-28
DK533189D0 (da) 1989-10-26
CA2001264A1 (fr) 1990-04-27
NO173097B (no) 1993-07-19

Similar Documents

Publication Publication Date Title
ZA899671B (en) Phosphinic acid substituted steroids as inhibitors of steroid 5-alpha-reductase
ZA88549B (en) Steroid 5-alpha-reductase inhibitors
DE3570038D1 (en) Steroids for use as immunomodulators
IL92103A0 (en) 3beta,17beta-hydroxy-substituted steroids,related steroidal compounds and pharmaceutical compositions containing them
GR3033524T3 (en) Steroids which inhibit angiogenesis.
PH29913A (en) Contraception method using competitive progesterone antagonists and novel compounds useful therein
IL175398A0 (en) Steroidal compounds and pharmaceutical compositions containing them for treating oxidative stress and inflammation
GR3032257T3 (en) 17-Spiromethylene steroids
ZA899670B (en) Phosphonic acid substituted steroids as steroid 5-alpha-reductase inhibitors
DE3560902D1 (en) Vitamin d3 derivatives
IL88396A (en) Preparation of 6-methylene derivatives of androsta-1,4- diene-3,17-diones and pharmaceutical compositions containing them
DE3760277D1 (en) New 6- or 7-methylenandrosta-1, 4-diene-3,17-dione derivatives and process for their preparation
AP9300589A0 (en) Novel 17a and 17b substituted acyl-3-carboxy 3,5-diene steroidal compounds, pharmaceutical compositions containing these compounds, and methods for using these compounds to inhibit steroid 5-a-reductase.
ES2083254T3 (es) Composiciones para la administracion topica de espironolactona.
GB2188932B (en) Steroidal compounds and process for lengthening the side-chain of certain steroids
BG102716A (en) Method for the treatment of cardiac insufficiency by means of formulations opposing the endotheline
GR3025872T3 (en) Orally active derivatives of 1,3,5(10)-estratriene
EP0559706A4 (fr)
ZA924665B (en) Substituted 16-methyl steroid derivatives of pregna-1, 4-dien-3,20-doine, their preparation, their use in the preparation of 16-methylene steroids and intermediates.
RU95113491A (ru) Новые стероиды, способ лечения, фармацевтическая композиция, способы получения

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)

Owner name: AVENTIS INC.

Free format text: FORMER NAME:MERRELL PHARMACEUTICALS INC.